Altamira Therapeutics Announces Publication of Positive
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis...
Stay updated with breaking news from Rhinoconjunctivitis Quality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis...
HAMILTON, BERMUDA , Sept. 14, 2023 -- Fresh data from randomized controlled NASAR clinical trial further demonstrate efficacy and tolerability of Bentrio® nasal spray in treatment of...
Results from the CLARITY Study Show the NEUROMARK® System Provides Safe and Effective Treatment for Patients with Chronic Rhinitis Neurent Medical, a company pioneering innovative non-surgical interventions
Corticosteroid plus an antihistamine improves nasal and ocular allergic rhinitis better than corticosteroid alone, researchers in Korea report.